Is it ethical to use a placebo? The answer to this questionwill depend, I suggest, upon whether there is already availablean orthodox treatment of proved or accepted value. If thereis such an orthodox treatment the question will hardly arise,for the doctor will wish to know whether a new treatment ismore, or less, effective than the old, not that it is more effectivethan nothing.
-- A. Bradford Hill1
Unaccountably, in these times of raised ethical consciousness,placebo treatments are still commonly used in medical researchin circumstances in which their use is unethical. We refer . . . [Full Text of this Article]
The Ethics of Placebo Controls
Ivermectin Trial
Rheumatoid Arthritis Trials
Antidepressant-Drug Trials
Ondansetron Trials
Trials of Drugs for Congestive Heart Failure
Antihypertensive-Drug Trials
Placebo Controls and Drug Approval
Is There a Scientific Rationale for Placebos?
Establishing a Reference Point
Avoiding Difficult Decisions about Comparison Treatments
Bolstering Statistical Significance
Ethical Counterarguments
Recommendations
References
Related Letters:
The Use of Placebo Controls
Schechter C., Cagliano S., Traversa G., Taylor H. R., Nash S. D., Gilbert E. M., Packer M., Cleophas T. J.M., Pohl R., Balon R., Denny W. F., Sramek J. J., Cutler N. R., Solomon D. A., Rothman K. J., Michels K. B.
Extract |
Full Text
N Engl J Med 1995;
332:60-62, Jan 5, 1995.
Correspondence
This article has been cited by other articles:
Dunlop, B W, Banja, J
(2009). A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders. J. Med. Ethics
35: 384-389
[Abstract][Full Text]
Calton, T., Spandler, H.
(2009). Minimal-medication approaches to treating schizophrenia. Adv. Psychiatr. Treat.
15: 209-217
[Abstract][Full Text]
Zaslawski, C.
(2008). Ethical Considerations for Acupuncture and Chinese Herbal Medicine Clinical Trials: A Cross-cultural Perspective. Evid Based Complement Alternat Med
0: nen055v1-nen055
[Abstract][Full Text]
Kotzalidis, G., Pacchiarotti, I., Manfredi, G., Savoja, V., Torrent, C., Mazzarini, L., Tatarelli, C., Amann, B., Di Marzo, S., Sanchez-Moreno, J., Sani, G., Girardi, P., Colom, F., Vieta, E.
(2008). Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration?. J Psychopharmacol
22: 590-597
[Abstract]
Gomberg-Maitland, M.
(2008). Traditional and Alternative Designs for Pulmonary Arterial Hypertension Trials. Proc Am Thorac Soc
5: 610-616
[Abstract][Full Text]
Halpern, S. D., Doyle, R., Kawut, S. M.
(2008). The Ethics of Randomized Clinical Trials in Pulmonary Arterial Hypertension. Proc Am Thorac Soc
5: 631-635
[Abstract][Full Text]
Smith, P. B., Li, J. S., Murphy, M. D., Califf, R. M., Benjamin, D. K. Jr
(2008). Safety of Placebo Controls in Pediatric Hypertension Trials. Hypertension
51: 829-833
[Abstract][Full Text]
Djulbegovic, B., Kumar, A., Soares, H. P., Hozo, I., Bepler, G., Clarke, M., Bennett, C. L.
(2008). Treatment Success in Cancer: New Cancer Treatment Successes Identified in Phase 3 Randomized Controlled Trials Conducted by the National Cancer Institute-Sponsored Cooperative Oncology Groups, 1955 to 2006. Arch Intern Med
168: 632-642
[Abstract][Full Text]
Kim, M. K., Lee, J.-L., Hyun, M. S., Do, Y. R., Song, H. S., Kim, J. G., Bae, S. H., Ryoo, H. M., Park, K. U., Lee, K. H.
(2008). Palliative Chemotherapy Preferences and Factors that Influence Patient Choice in Incurable Advanced Cancer. Jpn J Clin Oncol
0: hym147v1-7
[Abstract][Full Text]
Blumenthal, J. A, Sherwood, A., Rogers, S. D., Babyak, M. A., Murali Doraiswamy, P., Watkins, L., Hoffman, B. M., O'Connell, C., Johnson, J. J., Patidar, S. M., Waugh, R., Hinderliter, A.
(2007). Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study rationale, design, and methodological issues. Clin Trials
4: 548-559
[Abstract]
Glasser, S. P., Howard, G.
(2006). Clinical trial design issues: at least 10 things you should look for in clinical trials.. J Clin Pharmacol
46: 1106-1115
[Abstract][Full Text]
Rajagopal, S.
(2006). The placebo effect. Psychiatr. Bull.
30: 185-188
[Full Text]
Bola, J. R
(2006). Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm?. Schizophr Bull
32: 288-296
[Abstract][Full Text]
Miller, F. G, Wendler, D.
(2006). The Relevance of Empirical Research in Bioethics. Schizophr Bull
32: 37-41
[Abstract][Full Text]
Fischer, B. A IV
(2006). A Summary of Important Documents in the Field of Research Ethics. Schizophr Bull
32: 69-80
[Abstract][Full Text]
Nagasako, E. M., Kalauokalani, D. A.
(2005). Ethical aspects of placebo groups in pain trials: Lessons from psychiatry. Neurology
65: S59-S65
[Abstract][Full Text]
Kumar, A., Soares, H., Wells, R., Clarke, M., Hozo, I., Bleyer, A., Reaman, G., Chalmers, I., Djulbegovic, B.
(2005). Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group. BMJ
331: 1295-
[Abstract][Full Text]
Kemmler, G., Hummer, M., Widschwendter, C., Fleischhacker, W. W.
(2005). Dropout Rates in Placebo-Controlled and Active-Control Clinical Trials of Antipsychotic Drugs: A Meta-analysis. Arch Gen Psychiatry
62: 1305-1312
[Abstract][Full Text]
Holdsworth, M. T, Vo-Nguyen, T.
(2005). Employment of Substandard Antiemetic Prophylaxis in Recent Trials of Chemotherapy-Induced Nausea and Vomiting. The Annals of Pharmacotherapy
39: 1903-1910
[Abstract][Full Text]
Morreim, E. H.
(2005). The Clinical Investigator as Fiduciary: Discarding a Misguided Idea. J Law Med Ethics
33: 586-598
Woods, S. W., Gueorguieva, R. V., Baker, C. B., Makuch, R. W.
(2005). Control Group Bias in Randomized Atypical Antipsychotic Medication Trials for Schizophrenia. Arch Gen Psychiatry
62: 961-970
[Abstract][Full Text]
SMITH, A., JAINER, A. K., BENNET, C.
(2005). Sertraline for Recurrent Major Depression. Am. J. Psychiatry
162: 1025-1026
[Full Text]
Storosum, J. G., Wohlfarth, T., Gispen-de Wied, C. C., Linszen, D. H., Gersons, B. P.R., van Zwieten, B. J., van den Brink, W.
(2005). Suicide Risk in Placebo-Controlled Trials of Treatment for Acute Manic Episode and Prevention of Manic-Depressive Episode. Am. J. Psychiatry
162: 799-802
[Abstract][Full Text]
Breitbart, W., Marotta, R., Platt, M. M., Weisman, H., Derevenco, M., Grau, C., Corbera, K., Raymond, S., Lund, S., Jacobsen, P.
(2005). A Double-Blind Trial of Haloperidol, Chlorpromazine, and Lorazepam in the Treatment of Delirium in Hospitalized AIDS Patients. Focus
3: 333-340
[Abstract][Full Text]
Kavanaugh, A
(2005). Ethical and practical issues in conducting clinical trials in psoriasis and psoriatic arthritis. Ann Rheum Dis
64: ii46-ii48
[Abstract][Full Text]
Soares, H. P., Kumar, A., Daniels, S., Swann, S., Cantor, A., Hozo, I., Clark, M., Serdarevic, F., Gwede, C., Trotti, A., Djulbegovic, B.
(2005). Evaluation of New Treatments in Radiation Oncology: Are They Better Than Standard Treatments?. JAMA
293: 970-978
[Abstract][Full Text]
SUNDARARAJAN, V., JAINER, A. K.
(2004). A Mood Stabilizer With Risperidone or Haloperidol for Mania. Am. J. Psychiatry
161: 2139-2140
[Full Text]
Kawut, S.M., Palevsky, H.I.
(2004). New answers raise new questions in pulmonary arterial hypertension. Eur Respir J
23: 799-801
[Full Text]
Wendler, D., Emanuel, E. J., Lie, R. K.
(2004). The Standard of Care Debate: Can Research in Developing Countries Be Both Ethical and Responsive to Those Countries' Health Needs?. AJPH
94: 923-928
[Abstract][Full Text]
Kent, D. M., Fendrick, A. M., Langa, K. M.
(2004). New and Dis-Improved: On the Evaluation and Use of Less Effective, Less Expensive Medical Interventions. Med Decis Making
24: 281-286
[Abstract]
Spuls, P. I., Witkamp, L., Bossuyt, P. M. M., Bos, J. D.
(2004). The Course of Chronic Plaque-Type Psoriasis in Placebo Groups of Randomized Controlled Studies. Arch Dermatol
140: 338-344
[Abstract][Full Text]
Miller, F. G., Silverman, H. J.
(2004). The Ethical Relevance of the Standard of Care in the Design of Clinical Trials. Am. J. Respir. Crit. Care Med.
169: 562-564
[Full Text]
Miller, F. G., Emanuel, E. J., Rosenstein, D. L., Straus, S. E.
(2004). Ethical Issues Concerning Research in Complementary and Alternative Medicine. JAMA
291: 599-604
[Abstract][Full Text]
Leon, A. C., Solomon, D. A.
(2003). Toward Rapproachment in the Placebo Control Debate: A Calculated Compromise of Power. Eval Health Prof
26: 404-414
[Abstract]
Stolk, P., ten Berg, M. J, Hemels, M. E., Einarson, T. R
(2003). Meta-Analysis of Placebo Rates in Major Depressive Disorder Trials. The Annals of Pharmacotherapy
37: 1891-1899
[Abstract][Full Text]
Beydoun, A., Kutluay, E.
(2003). Conversion to monotherapy: Clinical trials in patients with refractory partial seizures. Neurology
60: S13-25
[Abstract][Full Text]
Pickar, D., Bartko, J. J.
(2003). Effect Size of Symptom Status in Withdrawal of Typical Antipsychotics and Subsequent Clozapine Treatment in Patients With Treatment-Resistant Schizophrenia. Am. J. Psychiatry
160: 1133-1138
[Abstract][Full Text]
Lauer, M. S., Topol, E. J.
(2003). Clinical Trials--Multiple Treatments, Multiple End Points, and Multiple Lessons. JAMA
289: 2575-2577
[Full Text]
Storosum, J. G., van Zwieten, B. J., Wohlfarth, T., de Haan, L., Khan, A., van den Brink, W.
(2003). Suicide Risk in Placebo vs Active Treatment in Placebo-Controlled Trials for Schizophrenia. Arch Gen Psychiatry
60: 365-368
[Abstract][Full Text]
Carpenter, W. T. Jr., Appelbaum, P. S., Levine, R. J.
(2003). The Declaration of Helsinki and Clinical Trials: A Focus on Placebo-Controlled Trials in Schizophrenia. Am. J. Psychiatry
160: 356-362
[Abstract][Full Text]
Bekelman, J. E., Li, Y., Gross, C. P.
(2003). Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review. JAMA
289: 454-465
[Abstract][Full Text]
JAINER, A. K., ONALAJA, O.A.
(2003). Consolidated Standard of Reporting Trials Guidelines. Am. J. Psychiatry
160: 191-192
[Full Text]
London, A. J., Kadane, J. B.
(2002). Placebos that harm: sham surgery controls in clinical trials. Stat Methods Med Res
11: 413-427
[Abstract]
Naldi, L.
(2002). Alefacept for Psoriasis: Promising Drug, Open Questions. Arch Dermatol
138: 1238-1240
[Full Text]
Miller, F. G., Shorr, A. F.
(2002). Unnecessary Use of Placebo Controls: The Case of Asthma Clinical Trials. Arch Intern Med
162: 1673-1677
[Full Text]
Campbell, C., Jainer, A. K., Michelson, D.
(2002). Is it ethical to use a placebo? * Author's reply. Br. J. Psychiatry
180: 548-549
[Full Text]
Walsh, B. T., Seidman, S. N., Sysko, R., Gould, M.
(2002). Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing. JAMA
287: 1840-1847
[Abstract][Full Text]
Kupfer, D. J., Frank, E.
(2002). Placebo in Clinical Trials for Depression: Complexity and Necessity. JAMA
287: 1853-1854
[Full Text]
(2002). The better-than-nothing idea: debating the use of placebo controls. CMAJ
166: 573-573
[Full Text]
(2002). Debat sur l'utilisation des placebos controles. CMAJ
166: 575-575
[Full Text]
Charney, D. S., Nemeroff, C. B., Lewis, L., Laden, S. K., Gorman, J. M., Laska, E. M., Borenstein, M., Bowden, C. L., Caplan, A., Emslie, G. J., Evans, D. L., Geller, B., Grabowski, L. E., Herson, J., Kalin, N. H., Keck, P. E. Jr, Kirsch, I., Krishnan, K. R. R., Kupfer, D. J., Makuch, R. W., Miller, F. G., Pardes, H., Post, R., Reynolds, M. M., Roberts, L., Rosenbaum, J. F., Rosenstein, D. L., Rubinow, D. R., Rush, A. J., Ryan, N. D., Sachs, G. S., Schatzberg, A. F., Solomon, S., for the Consensus Development Panel,
(2002). National Depressive and Manic-Depressive Association Consensus Statement on the Use of Placebo in Clinical Trials of Mood Disorders. Arch Gen Psychiatry
59: 262-270
[Abstract][Full Text]
Emanuel, E. J., Miller, F. G.
(2001). The Ethics of Placebo-Controlled Trials -- A Middle Ground. NEJM
345: 915-919
[Full Text]
Storosum, J. G., van Zwieten, B. J., van den Brink, W., Gersons, B. P.R., Broekmans, A. W.
(2001). Suicide Risk in Placebo-Controlled Studies of Major Depression. Am. J. Psychiatry
158: 1271-1275
[Abstract][Full Text]
Orentlicher, D.
(2001). Placebo-Controlled Trials of New Drugs: Ethical Considerations. Diabetes Care
24: 771-772
[Full Text]
Rosato, J.
(2000). The Ethics of Clinical Trials: A Chad's View. J Law Med Ethics
28: 362-378
(2000). Correction: Ethics of Placebo-Controlled Trials. ANN INTERN MED
133: 754-754
[Full Text]
Rubin, R. T., Umanoff, D. F., Veijola, J. M., Duncan, B. L., Miller, S. D., Keller, M. B., Klein, D. N., Thase, M. E.
(2000). Nefazodone, Psychotherapy, and Their Combination for Chronic Depression. NEJM
343: 1041-1043
[Full Text]
Temple, R., Ellenberg, S. S.
(2000). Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues. ANN INTERN MED
133: 455-463
[Abstract][Full Text]
Ellenberg, S. S., Temple, R.
(2000). Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases. ANN INTERN MED
133: 464-470
[Abstract][Full Text]
Simon, R.
(2000). Are Placebo-Controlled Clinical Trials Ethical or Needed When Alternative Treatment Exists?. ANN INTERN MED
133: 474-475
[Full Text]
Rothman, K. J, Michels, K. B, Baum, M.
(2000). For and against: Declaration of Helsinki should be strengthened FOR AGAINST Rothman and Michels' riposte. BMJ
321: 442-445
[Full Text]
Rabins, P. V., Black, B. S., Roca, R., German, P., McGuire, M., Robbins, B., Rye, R., Brant, L.
(2000). Effectiveness of a Nurse-Based Outreach Program for Identifying and Treating Psychiatric Illness in the Elderly. JAMA
283: 2802-2809
[Abstract][Full Text]
Emanuel, E. J., Wendler, D., Grady, C.
(2000). What Makes Clinical Research Ethical?. JAMA
283: 2701-2711
[Abstract][Full Text]
Preston, R. A., Materson, B. J., Reda, D. J., Williams, D. W.
(2000). Placebo-Associated Blood Pressure Response and Adverse Effects in the Treatment of Hypertension: Observations From a Department of Veterans Affairs Cooperative Study. Arch Intern Med
160: 1449-1454
[Abstract][Full Text]
Leber, P.
(2000). Placebo Controls: No News Is Good News. Arch Gen Psychiatry
57: 319-320
[Full Text]
Michels, K. B.
(2000). The Placebo Problem Remains. Arch Gen Psychiatry
57: 321-322
[Full Text]
Craig, T. J., Bromet, E. J., Fennig, S., Tanenberg-Karant, M., Lavelle, J., Galambos, N.
(2000). Is There an Association Between Duration of Untreated Psychosis and 24-Month Clinical Outcome in a First-Admission Series?. Am. J. Psychiatry
157: 60-66
[Abstract][Full Text]
Freeman, T. B., Vawter, D. E., Leaverton, P. E., Godbold, J. H., Hauser, R. A., Goetz, C. G., Olanow, C. W.
(1999). Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's Disease. NEJM
341: 988-992
[Full Text]
Macklin, R.
(1999). The Ethical Problems with Sham Surgery in Clinical Research. NEJM
341: 992-996
[Full Text]
Miller, F. G., Pickar, D., Rosenstein, D. L.
(1999). Addressing Ethical Issues in the Psychiatric Research Literature. Arch Gen Psychiatry
56: 763-764
[Full Text]
Shorr, A. F., Miller, F. G.
(1999). Psychotherapy for Depression in Diabetes. ANN INTERN MED
131: 70-70
[Full Text]
Quitkin, F. M.
(1999). Placebos, Drug Effects, and Study Design: A Clinician's Guide. Am. J. Psychiatry
156: 829-836
[Abstract][Full Text]
Chadwick, D.
(1999). Does withdrawal of different antiepileptic drugs have different effects on seizure recurrence?: Further results from the MRC Antiepileptic Drug Withdrawal Study. Brain
122: 441-448
[Abstract][Full Text]
Chadwick, D., Privitera, M.
(1999). Placebo-controlled studies in neurology. Neurology
52: 681-681
[Full Text]
Orr, R. D., Shafrir, Y., Rosman, N. P., Cloyd, J. C., Bell, W. E.
(1998). Treatment of Acute Repetitive Seizures. NEJM
339: 1856-1857
[Full Text]
Malone, R. P., Simpson, G. M.
(1998). Psychopharmacology : Use of Placebos in Clinical Trials Involving Children and Adolescents. Psychiatr. Serv.
49: 1413-1417
[Full Text]
Karlawish, J. H. T., Whitehouse, P. J.
(1998). Is the Placebo Control Obsolete in a World After Donepezil and Vitamin E?. Arch Neurol
55: 1420-1424
[Abstract][Full Text]
Knopman, D., Kahn, J., Miles, S.
(1998). Clinical Research Designs for Emerging Treatments for Alzheimer Disease: Moving Beyond Placebo-Controlled Trials. Arch Neurol
55: 1425-1429
[Abstract][Full Text]
Tramèr, M. R, Reynolds, D J. M, Moore, R A., McQuay, H. J
(1998). When placebo controlled trials are essential and equivalence trials are inadequate. BMJ
317: 875-880
[Full Text]
Roberts, L. W., Solomon, Z., Roberts, B. B., Keith, S. J.
(1998). Ethics in Psychiatric Research: Resources for Faculty Development and Resident Education. Acad. Psychiatry
22: 1-20
[Abstract][Full Text]
Carroll, K. M.
(1997). Manual-Guided Psychosocial Treatment: A New Virtual Requirement for Pharmacotherapy Trials?. Arch Gen Psychiatry
54: 923-928
[Abstract]
Hardy, J.
(1997). Placebo-controlled trials in palliative care: the argument for. Palliat Med
11: 415-418
FUSON, R. L., SHERMAN, M., VAN VLEET, J., WENDT, T.
(1997). Current Concepts Review - The Conduct of Orthopaedic Clinical Trials. JBJS
79: 1089-98
[Full Text]
Carpenter, W. T. Jr, Schooler, N. R., Kane, J. M.
(1997). The Rationale and Ethics of Medication-Free Research in Schizophrenia. Arch Gen Psychiatry
54: 401-407
[Abstract]
Strauss, D., Kastner, T., Ashwal, S., White, J.
(1997). Tubefeeding and Mortality in Children With Severe Disabilities and Mental Retardation. Pediatrics
99: 358-362
[Abstract][Full Text]
Elliott, C.
(1997). Caring About Risks: Are Severely Depressed Patients Competent to Consent to Research?. Arch Gen Psychiatry
54: 113-116
[Abstract]
Hirschfeld, R. M. A., Winslade, W., Krause, T. L.
(1997). Protecting Subjects and Fostering Research: Striking the Proper Balance. Arch Gen Psychiatry
54: 121-123
[Abstract]
Po, A L. W., Zhang, W Y
(1996). Paracetamol-codeine combinations versus paracetamol alone. BMJ
313: 1209-1209
[Full Text]
Alves, W. A., Macciocchi, S. N.
(1996). Ethical Considerations in Clinical Neuroscience: Current Concepts in Neuroclinical Trials. Stroke
27: 1903-1909
[Abstract][Full Text]
Freedman, B., Weijer, C., Glass, K. C.
(1996). Placebo Orthodoxy in Clinical Research I: Empirical and Methodological Myths. J Law Med Ethics
24: 243-251
Freedman, B., Glass, K. C., Weijer, C.
(1996). Placebo Orthodoxy in Clinical Research II: Ethical, Legal, and Regulatory Myths. J Law Med Ethics
24: 252-259
Jones, B, Jarvis, P, Lewis, J A, Ebbutt, A F
(1996). Trials to assess equivalence: the importance of rigorous methods. BMJ
313: 36-39
[Full Text]
Cicardi, M., Agostoni, A.
(1996). Hereditary Angioedema. NEJM
334: 1666-1667
[Full Text]
Orr, R. D.
(1996). Clozapine for Treatment of Schizophrenia. JAMA
275: 186-187
[Abstract]
Collier, J.
(1995). Confusion over use of placebos in clinical trials. BMJ
311: 821-822
[Full Text]
Aspinall, R. L, Goodman, N. W
(1995). Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials. BMJ
311: 844-846
[Abstract][Full Text]
Ernst, E, Resch, K L
(1995). Concept of true and perceived placebo effects. BMJ
311: 551-553
[Full Text]
Koopmans, P P
(1995). Registration of drugs for treating cancer and HIV infection: a plea to carry out phase 3 trials before admission to the market. BMJ
310: 1305-1306
[Full Text]
Previous
